Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Self-labeling enzyme tag (for covalent protein labeling) (None universally accepted; uses commercial names like "HaloTag," "SNAP-tag," and "CLIP-tag")
- Target
- None universally accepted; uses commercial names like "HaloTag," "SNAP-tag," and "CLIP-tag"
- Molecular classification
- Enzyme (engineered), Protein tag (research tool), Other (platform/technology)
01
Overview
Self-labeling enzyme tag systems are engineered, genetically encodable protein tags that enable the specific and covalent attachment of synthetic molecules—such as fluorescent dyes or drug payloads—to proteins of interest, including antibodies. Notable systems include HaloTag, SNAP-tag, and CLIP-tag, which operate by fusing the tag to a target protein and introducing a functionalized substrate that reacts selectively and irreversibly under physiological conditions. This technology streamlines live-cell imaging, multiplexed studies, and targeted delivery applications by providing modularity, high specificity, and rapid quantitative labeling. The system itself is not a molecular target or therapeutic receptor; rather, it is a widely adopted platform for protein engineering, visualization, and bioconjugation in biomedical research
- Other names
- Self-labeling protein tagCovalent labeling tagProtein fusion tagHaloTagSNAP-tagCLIP-tag
02
Mechanism of action
Covalent attachment of a synthetic substrate to the engineered enzyme tag fused to a target protein
03
Biological functions
Protein labelingCovalent attachmentVisualization (bioimaging)BiosensingTargeted conjugation (e.g., antibody-drug conjugates)
04
Disease associations
None intrinsically; used in research and diagnostics, sometimes therapeutics (e.g., for developing antibody-drug conjugates or targeted imaging)
05
Safety considerations
Not applicable for the platform; potential concerns are experimental (e.g., off-target labeling, perturbation of protein function if fusion disrupts structure), but not clinical toxicity
06
Interacting drugs
None; interacts with synthetic probes (fluorophores, affinity components, payloads), not drugs per se
07
Biomarkers
None; technology is not used for direct biomarker measurement, but can facilitate biomarker studies when fused to biomarker-specific antibodies
Beyond the preview
Go deeper on Self-labeling enzyme tag (for covalent protein labeling) (None universally accepted; uses commercial names like "HaloTag," "SNAP-tag," and "CLIP-tag").
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Self-labeling enzyme tag (for covalent protein labeling) (None universally accepted; uses commercial names like "HaloTag," "SNAP-tag," and "CLIP-tag").